当前位置:药药网 / 数据中心 / PubMed 中的摘要说明,变体和药物之间的可能关系
奥美拉唑
文献标题
Efavirenz-mediated induction of omeprazole metabolism is CYP2C19 genotype dependent.
杂志
The pharmacogenomics journal
句子
Third, reduction in AUC 0-鈭?of omeprazole and increase in metabolic ratio of 5-hydroxylation (changed from 0.04 to 0.08) observed in one PM subject (current study) are consistent with previous studies showing an increased omeprazole clearance in CYP2C19 PM after treatment with St-John's Wort or artemisinin. , Considering that CYP2C19*2*2 is associated with a complete absence of CYP2C19 activity, the induction observed in our PM subject and the magnitude thereof may be explained by induction of other non-CYP2C19-mediated metabolic pathways of omeprazole (e.g., CYP3A-mediated sulfoxidation).